Skip to main content
Clinical Trials/NL-OMON52734
NL-OMON52734
Recruiting
Not Applicable

Senescence and the early ageing phenotype after chemotherapy for testicular cancer: the SEA-CAT study - SEA-CAT study

niversitair Medisch Centrum Groningen0 sites192 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Testicular cancer
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
192
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Cross\-sectional part of this study:
  • \- Diagnosed with metastatic testicular cancer in 1999\-2019 and participated in
  • the above mentioned longitudinal studies (stage II or higher)
  • \- Received first\-line cisplatin\-based chemotherapy
  • \- Was younger than 50 years of age at start of chemotherapy, Longitudinal part
  • of this study:
  • Chemotherapy\-group:
  • \- Diagnosis of metastatic testicular cancer (stage II or higher)
  • \- Is about to start with first\-line cisplatin\-based chemotherapy
  • \- Younger than 50 years of age at diagnosis of metastatic testicular cancer,

Exclusion Criteria

  • \- Earlier diagnosis with another malignancy except from successfully treated
  • squamous cell carcinoma of the skin.
  • \- Not able to provide informed consent (in example in case of mental or
  • psychiatric disability)

Outcomes

Primary Outcomes

Not specified

Similar Trials